CLINICAL_TRIALS
trial_result
· 2017-02-24
Clinical Trial Update: Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging [Phase 1]
Summary
Phase 1 trial evaluating response of brain metastases to Gamma Knife radiosurgery, assessed with dynamic susceptibility-weighted contrast-enhanced perfusion MRI…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Washington University School of Medicine | Conditions: Brain Metastases | Phase 1 | Status: COMPLETED